JP Morgan Chase
GSKH

JP Morgan Chase’s GSK PLC ADRhedged GSKH Stock Holding History

JP Morgan Chase’s Portfolio GSKH Stock Details GSKH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74 Hold
1
– – ﹤0.01% 7558
2026
Q1 		$77 Buy
+1
New +$76 ﹤0.01% 7328

Other funds holding GSKH

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's GSKH Position: Q2 2026 in Review

JP Morgan Chase held its GSK PLC ADRhedged (GSKH) position steady in Q2 2026 at 1 share worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #7558.

JP Morgan Chase first reported a position in GSKH in Q1 2026 and has held it in 2 quarters since. The position peaked at $77 in Q1 2026. 2 funds tracked by Wall St. Rank hold GSKH as of Q2 2026.

  • JP Morgan Chase held 1 share of GSK PLC ADRhedged worth $74 as of Q2 2026.
  • JP Morgan Chase left its GSK PLC ADRhedged share count unchanged in Q2 2026.
  • GSK PLC ADRhedged made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7558 holding.
  • JP Morgan Chase first reported a position in GSK PLC ADRhedged in Q1 2026 and has held it in 2 quarters since.
  • JP Morgan Chase's GSK PLC ADRhedged position peaked at $77 in Q1 2026.
  • 2 funds tracked by Wall St. Rank held GSK PLC ADRhedged as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.